Amylin

Traders Call Bottom in Amylin
Seeking Alpha
Wed, 08/25/10 - 12:33 pm
Amylin
How Long Can Amylin Pharmaceuticals Last?
Motley Fool
Wed, 08/18/10 - 07:33 am
Amylin
Amylin Pharmaceuticals: Warming Up or Cooling Off?
Motley Fool
Sat, 08/7/10 - 11:44 am
Amylin
investors
Big Biotech: End of an Era
Seeking Alpha
Wed, 07/28/10 - 10:17 am
Alexion
Amgen
Amylin
Biogen Idec
Biomarin
Celgene
Genentech
Dendreon
Genzyme
Gilead Sciences
GSK
Roche
Human Genome Sciences
Vertex Pharmaceuticals
Sanofi
It's All About the Future for Amylin
Motley Fool
Thu, 07/22/10 - 03:49 pm
Amylin
Bydureon
Byetta
diabetes
Novo Nordisk
Victoza
Merck
Januvia
Takeda
Actos
Onglyza
AstraZeneca
Into The Wild West: Biotech Trading
CNBC
Thu, 07/15/10 - 09:06 am
biotech
Amylin
Genzyme
Human Genome Sciences
If Avandia falls, which diabetes meds fill the gap?
Fierce Pharma
Wed, 07/14/10 - 12:09 pm
diabetes
GSK
Avandia
Actos
Takeda
Merck
Januvia
Novo Nordisk
Victoza
Eli Lilly
Byetta
Amylin
Onglyza
AstraZeneca
Bristol-Myers Squibb
Diabetes Drug Development Pops and Drops
Motley Fool
Wed, 06/30/10 - 09:57 am
diabetes
Orexigen
Contrave
Avandia
GSK
Merck
Eli Lilly
Amylin
Novo Nordisk
JNJ
MannKind
Afrezza
Amylin's New Diabetes Drug Well Tolerated By Sufferers
CNBC
Mon, 06/28/10 - 02:59 pm
Amylin
diabetes
Bydureon
type 2 diabetes
Improvement in Beta-Cell Function Observed After Three Years of BYETTA(R) Therapy: Data Presented at ADA 2010
Yahoo/PR NewsWire
Sun, 06/27/10 - 10:56 am
Eli Lilly
Amylin
Byetta
diabetes
type 1 diabetes
Meta-Analysis of SYMLIN(R) Clinical Data Showed No Increased Risk of Cardiovascular Adverse Events Associated With SYMLIN Treatment in Patients With Type 2 Diabetes
Yahoo/PR NewsWire
Sun, 06/27/10 - 10:54 am
Symlin
Amylin
diabetes
type 1 diabetes
Study Finds BYETTA(R) Use Was Not Associated With Increased Rate of Acute Pancreatitis Compared to Other Antidiabetic Drugs
Trading Markets
Sat, 06/26/10 - 11:19 am
Eli Lilly
Byetta
Amylin
diabetes
Roche’s Taspoglutide Works Better Than Lantus, Byetta in Trials
BusinessWeek
Sat, 06/26/10 - 10:29 am
Roche
taspoglutide
Sanofi
Eli Lilly
Amylin
Byetta
Merck
Januvia
diabetes
Diabetes drug makers gain ahead of conference
MarketWatch
Sat, 06/26/10 - 09:13 am
Arca pharmaceutical index
MannKind
Amylin
Molecular Insight
diabetes
Drug Pipeline Pulse Check: Roche’s Stumble Boosts Amylin
Seeking Alpha
Thu, 06/24/10 - 10:11 am
Roche
Amylin
diabetes
taspoglutide
Amylin Soars on Roche’s Diabetes Delay
Barron's
Sat, 06/19/10 - 12:55 pm
Amylin
Roche
type 2 diabetes
Bydureon
Heavy Call Selling Seen on Amylin Pharma (AMLN)
benzinga
Sat, 06/19/10 - 12:32 pm
Amylin
investors
Amylin, Alkermes gain ground on Roche drug delay
Yahoo/AP
Fri, 06/18/10 - 11:28 am
Roche
Amylin
Alkermes
diabetes
taspoglutide
Amylin Drug Fails To Beat Generic
Forbes
Tue, 06/15/10 - 12:36 pm
generics
Amylin
metformin
diabetes
Bydureon
Byetta
Eli Lilly
BYDUREON™ FDA Review Timeline Set With PDUFA Action Date Of October 22, 2010
Medical News Today
Sun, 05/9/10 - 12:49 pm
Bydureon
Amylin
Eli Lilly
Alkermes
type 2 diabetes

Pages